http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015534980-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
filingDate 2013-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2015534980-A
titleOfInvention Topical steroid compositions and methods
abstract According to the present invention, a stably storable topical lotion composition for treating corticosteroid-responsive skin disease is provided, which includes halobetasol or a pharmaceutically acceptable salt, ester, and solvate thereof. And a pharmaceutically acceptable product comprising (a) one or more fatty alcohols and / or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate. A carrier is included. According to the present invention, a stably storable topical lotion composition for treating corticosteroid-responsive skin diseases is provided, comprising 0.05% halobetasol propionate, and (a) one or more fats A pharmaceutically acceptable carrier comprising alcohol and / or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate is included.
priorityDate 2012-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0040250-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523006
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260480
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID185639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536864
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23368
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21414
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474229
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426483830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426121993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10912684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415868567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415794900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538089
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524794
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24843097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415763637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421328696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030

Total number of triples: 87.